Characteristics and Clinical Application of Extracellular Vesicle-Derived DNA
- PMID: 34359729
- PMCID: PMC8345206
- DOI: 10.3390/cancers13153827
Characteristics and Clinical Application of Extracellular Vesicle-Derived DNA
Abstract
Extracellular vesicles (EVs) carry RNA, proteins, lipids, and diverse biomolecules for intercellular communication. Recent studies have reported that EVs contain double-stranded DNA (dsDNA) and oncogenic mutant DNA. The advantage of EV-derived DNA (EV DNA) over cell-free DNA (cfDNA) is the stability achieved through the encapsulation in the lipid bilayer of EVs, which protects EV DNA from degradation by external factors. The existence of DNA and its stability make EVs a useful source of biomarkers. However, fundamental research on EV DNA remains limited, and many aspects of EV DNA are poorly understood. This review examines the known characteristics of EV DNA, biogenesis of DNA-containing EVs, methylation, and next-generation sequencing (NGS) analysis using EV DNA for biomarker detection. On the basis of this knowledge, this review explores how EV DNA can be incorporated into diagnosis and prognosis in clinical settings, as well as gene transfer of EV DNA and its therapeutic potential.
Keywords: EV DNA; exosome; extracellular vesicle; gene transfer; liquid biopsy; methylation; microvesicle; next-generation sequencing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Gerber D.E. Targeted therapies: A new generation of cancer treatments. Am. Fam. Physician. 2008;77:311–319. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
